Discovering Genetic Signatures Associated with Alzheimer's Disease in Tiled Whole Genome Sequence Data: Results from the Artificial Intelligence for Alzheimer's Disease (AI4AD) Consortium
Zaranek, S. W.; Zaranek, A. W.; Amstutz, P.; Bao, J.; Chen, J.; Clegg, T.; Craft, H.; Jo, T.; Lee, B.; Nho, K.; Thomopoulos, S. I.; Davatzikos, C.; Shen, L.; Huang, H.; Thompson, P. M.; Saykin, A. J.; The Alzheimer's Disease Neuroimaging Initiative as a consortium author for the AI4AD Initiative,
Show abstract
Currently, the ability to analyze large-scale whole genome sequence (WGS) data is limited due to both the size of the data and the inability of many existing tools to scale. To address this challenge, we use data "tiling" to efficiently partition whole genome sequences into smaller segments resulting in a simple numeric matrix of small integers. This lossless representation is particularly suitable for machine learning (ML) models. As an example of the benefits of tiling, we showcase results from tiled data as part of the Artificial Intelligence for Alzheimers Disease (AI4AD) consortium. AI4AD is a coordinated initiative to develop transformative AI approaches for high throughput analysis of next generation sequencing and related imaging, AD biomarker, and cognitive data. The collective effort integrates imaging, genomic, biomarker, and cognitive data to address fundamental barriers in AD prevention and drug discovery. One of the projects initial aims is to discover new genetic signatures in WGS data that can be used to understand AD risk and progression in conjunction with imaging, biomarker and cognitive data. We tiled and analyzed 15,000+ genomes from the Alzheimers Disease Sequencing Project (ADSP) and the Alzheimers Disease Neuroimaging Initiative (ADNI). We tile 11,762 genomes, a subset of the release which does not include family-based datasets (AD Cases: 4,983, age range: 50-90 years, mean age: 73.8 years). We illustrate the use of tiled data in ML classification methods to predict phenotypes. Specifically, we identify and prioritize tile variants/genetic variants that are possible genetic signatures for AD. The model shows added predictive value from variants of genes previously found to be associated with AD risk, age of onset, neurofibrillary tangle measurements, and other AD-related traits-including the APOE variant (rs429358).
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Identifying and ranking potential driver genes of Alzheimer's Disease using multi-view evidence aggregation 96%
- CLEP: A Hybrid Data- and Knowledge- Driven Framework for Generating Patient Representations 95%
- Distinguishing Specific from Broad Genetic Associations between External Correlates and Common Factors 95%
Similar papers in this journal
- DYNATE: Localizing Rare-Variant Association Regions via Multiple Testing Embedded in an Aggregation Tree 94%
- Polygenic hazard score models for the prediction of Alzheimer's free survival using the lasso for Cox's proportional hazards model 93%
- Meta-MultiSKAT: Multiple phenotype meta-analysis for region-based association test 92%
Similar papers in this journal
- More accurate estimation of cell composition in bulk expression through robust integration of single-cell information 91%
- HTRX: an R package for learning non-contiguous haplotypes associated with a phenotype 91%
- Comparative genome analysis using sample-specific string detection in accurate long reads 90%
Similar papers in this journal
- MetaPhat: Detecting and decomposing multivariate associations from univariate genome-wide association statistics 93%
- Impute.me: an open source, non-profit tool for using data from DTC genetic testing to calculate and interpret polygenic risk scores. 92%
- Module analysis using single-patient differential expression signatures improve the power of association study for Alzheimer's disease 91%
Similar papers in this journal
- Genotyping TOMM40’523 Poly-T Polymorphisms Using Whole-Genome Sequencing 94%
- A Specialized Reference Panel with Structural Variants Integration for Improving Genotype Imputation in Alzheimer's Disease and Related Dementias (ADRD) 94%
- Integrating spatial transcriptomics and snRNA-seq data enhances differential gene expression analysis results of AD-related phenotypes 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.